FDA Approved: ABSORICA — Supplemental Application (Sun Pharmaceutical Industries, Inc.)

View source ↗

Summary

FDA approves a supplemental application for ABSORICA (isotretinoin) from Sun Pharmaceutical Industries, Inc., updating the labeling through a supplemental NDA.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acne Vulgaris

Drugs mentioned

• ABSORICA (isotretinoin)

Snippet

SUPPL AP for ABSORICA (ISOTRETINOIN)